Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function.
Eur J Pharmacol
; 933: 175267, 2022 Oct 15.
Article
in En
| MEDLINE
| ID: mdl-36122756
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19 Drug Treatment
Type of study:
Clinical_trials
/
Observational_studies
Limits:
Humans
Language:
En
Journal:
Eur J Pharmacol
Year:
2022
Document type:
Article
Affiliation country:
Iran
Country of publication:
Netherlands